Further extension of the PUSU Deadline
Toscafund granted extension to 3 September 2026 to announce firm offer decision at 250p per share.
- Proposed offer price 250 pence per share
Select text to share a quote on X · sign in to keep highlights & notes in your SPI notes
On 14 May 2026, the Company announced that it had received a revised non-binding proposal (the "Proposal") from funds advised by Toscafund Asset Management LLP ("Toscafund"), the Company's second largest shareholder, regarding a possible cash offer of 250 pence per Spire Healthcare share for the entire issued and to be issued ordinary share capital of Spire Healthcare (the "Cash Offer"). The Proposal includes an option for Spire Healthcare shareholders to elect for an unlisted rollover equity alternative in respect of some or all of their Spire Healthcare shares.
As set out in the Company's announcement on 6 August 2026, in accordance with Rule 2.6(a) of the Code, Toscafund is currently required, by not later than 5.00 p.m. (London time) on 21 August 2026 (the "PUSU Deadline"), either to: (i) announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code; or (ii) announce that it does not intend to make an offer for the Company.
Toscafund has confirmed to the Board that its due diligence has concluded and that it continues to work towards the announcement of a 250 pence per Spire Healthcare share recommended offer. Given that due diligence has concluded and the ongoing progress being made on transaction documentation, Toscafund has requested that the Board grants a further extension to enable it to finalise its financing arrangements, which are near-final.
Accordingly, the Board has therefore requested, and the Takeover Panel has consented to, a further extension to the PUSU Deadline. Consequently, in accordance with Rule 2.6(a) of the Code, Toscafund is now required, by not later than 5.00 p.m. (London time) on 3 September 2026, either to announce a firm intention to make an offer in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline may be further extended by the Company with the consent of the Takeover Panel, in accordance with Rule 2.6(c) of the Code.
This announcement is being made with the approval of Toscafund.
| J.P. Morgan Cazenove (Joint financial adviser and joint corporate broker) James Mitford / Alia Malik / Nikhil Gondalia | +44 | (0)20 | 3439 | 8000 |
| Berenberg (Joint corporate broker) Toby Flaux / Ben Wright / Detlir Elezi | +44 | (0)20 | 3207 | 7800 |
Notice related to financial advisers
Rule 26.1 disclosure
Additional Information
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.